A new diarylquinoline drug promises faster treatment for tuberculosis.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Identification of plant-derived natural products as potential inhibitors of the Mycobacterium tuberculosis proteasome
BMC Complementary and Alternative Medicine Open Access 15 October 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Andries, K. et al. Science 307, 223–227 (2005).
Nuermberger, E.L. et al. Am. J. Respir. Crit. Care Med. 169, 421–426 (2004).
Voskuil, M.I. et al. J. Exp. Med. 198, 705–713 (2003).
Dickinson, J., Guy, A. & Mitchison, D.A. Antimicrob. Agents Chemother. 36, 2066–2067 (1992).
Mitchison, D.A. J. Appl. Bacteriol. 81, 72S–80S (1996).
Brindle, R., Odhiambo, J. & Mitchison, D. BMC Pulm. Med. 1, 2 (2001).
Thangaraj, H.S., Phillips, R.O., Evans, M.R. & Wansbrough-Jones, M.H. Expert Rev. Anti Infect. Ther. 1, 217–222 (2003).
Mitchison, D.A. & Coates, A.R.M. Curr. Pharm. Des. 10, 3285–3295 (2004).
Global Alliance for Tuberculosis Drug Development. Tuberculosis 81 Suppl. 1, 1–52 (2001).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mitchison, D. Shortening the treatment of tuberculosis. Nat Biotechnol 23, 187–188 (2005). https://doi.org/10.1038/nbt0205-187
Issue Date:
DOI: https://doi.org/10.1038/nbt0205-187
This article is cited by
-
Identification of plant-derived natural products as potential inhibitors of the Mycobacterium tuberculosis proteasome
BMC Complementary and Alternative Medicine (2014)
-
Reviews and comment from the nature publishing group
Nature Reviews Microbiology (2005)